Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features.
Parikh, Rahul A
Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features. [electronic resource] - Clinical genitourinary cancer 02 2017 - 7-22 p. digital
Publication Type: Journal Article; Review
1938-0682
10.1016/j.clgc.2016.05.011 doi
Carcinoma, Renal Cell--drug therapy
Clinical Decision-Making
Clinical Trials as Topic
Drug Interactions
Humans
Kidney Neoplasms--drug therapy
Precision Medicine
Protein Kinase Inhibitors--pharmacology
TOR Serine-Threonine Kinases--antagonists & inhibitors
Treatment Outcome
Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features. [electronic resource] - Clinical genitourinary cancer 02 2017 - 7-22 p. digital
Publication Type: Journal Article; Review
1938-0682
10.1016/j.clgc.2016.05.011 doi
Carcinoma, Renal Cell--drug therapy
Clinical Decision-Making
Clinical Trials as Topic
Drug Interactions
Humans
Kidney Neoplasms--drug therapy
Precision Medicine
Protein Kinase Inhibitors--pharmacology
TOR Serine-Threonine Kinases--antagonists & inhibitors
Treatment Outcome